✦ LIBER ✦

Docetaxel in Hormone-Refractory Metastatic Prostate Cancer

✍ Scribed by Ronald de Wit

Book ID: 119928427
Publisher: Springer International Publishing AG
Year: 2005
Tongue: English
Weight: 50 KB
Volume: 65
Category: Article
ISSN: 0012-6667
DOI: 10.2165/00003495-200565160-00005

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Docetaxel in Hormone-Refractory Metastat

Docetaxel in Hormone-Refractory Metastatic Prostate Cancer

✍ William R. Berry 📂 Article 📅 2005 🏛 Springer International Publishing AG 🌐 English ⚖ 48 KB

Docetaxel in Hormone-Refractory Metastat

Docetaxel in Hormone-Refractory Metastatic Prostate Cancer

✍ William K. Oh 📂 Article 📅 2005 🏛 Springer International Publishing AG 🌐 English ⚖ 48 KB

Docetaxel and zoledronic acid in patient

Docetaxel and zoledronic acid in patients with metastatic hormone-refractory prostate cancer

✍ Dimitri Vordos; Bernard Paule; Francis Vacherot; Yves Allory; Laurent Salomon; A 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 70 KB

Docetaxel, low-dose estramustine, and do

Docetaxel, low-dose estramustine, and doxifluridine in hormone-refractory metastatic prostate cancer

✍ Yoshihiro Wada; Ken Kikuchi; Wataru Takahashi; Jiro Honda; Juro Nakanishi; Koich 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 409 KB

Weekly high-dose calcitriol and docetaxe

Weekly high-dose calcitriol and docetaxel in patients with metastatic hormone-refractory prostate cancer previously exposed to docetaxel

✍ Roberto Petrioli; Alessandra Pascucci; Edoardo Francini; Stefania Marsili; Angel 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 85 KB

A phase 2 study of carboplatin plus doce

A phase 2 study of carboplatin plus docetaxel in men with metastatic hormone-refractory prostate cancer who are refractory to docetaxel

✍ Robert W. Ross; Tomasz M. Beer; Susanna Jacobus; Glenn J. Bubley; Mary-Ellen Tap 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 79 KB 👁 2 views

## Abstract ## BACKGROUND. Prostate cancer is the second leading cause of cancer mortality among men in the U.S. To the authors' knowledge, there is no proven, effective, second‐line therapy for docetaxel‐refractory disease. Recent data suggest that platinum salts may be effective when combined wi